Vaginal Estrogen Utilization Among Medicare Beneficiaries With Genitourinary Syndrome of Menopause.

ABSTRACT:

Importance

Low-dose vaginal estrogen (VE) is a safe and effective treatment for genitourinary syndrome of menopause (GSM). The frequency of VE prescribing for GSM is unknown.

Objective

To evaluate VE prescriptions among women with GSM and to identify clinical phenotypes associated with VE claims.

Design, setting, and participants

This is a retrospective, population-based cohort study of a 20% random sample of Medicare fee-for-service beneficiaries enrolled in Parts A, B, and D from 2006 to 2018. Women aged 66 years and older with a diagnosis indicative of GSM were included. Exclusion criteria included diagnoses of breast and/or endometrial cancer within 6 months of GSM diagnosis. Data analysis was performed from October 2023 to June 2024.

Exposure

Diagnosis ind

SUBMITTER: Gallo K 

PROVIDER: S-EPMC12709372 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature